A61P 21 - Drugs for disorders of the muscular or neuromuscular system

Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
11/2011
11/23/2011	CN102256606A Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
11/23/2011	CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/23/2011	CN102247585A Chinese medicinal composition for treating rheumatism, preparation thereof and preparation method thereof
11/23/2011	CN102247577A Formula of traditional Chinese medicine washout powder and effervescent tablet for treating spondylodynia and preparation method thereof
11/23/2011	CN102247501A Medicine for treating soft tissue injury
11/23/2011	CN101698093B Drug composition oral preparation used for relaxing tendons and activating collaterals and preparation method thereof
11/23/2011	CN101336230B Pharmaceutical for use in the treatment of ureterolithiasis
11/22/2011	US8063087 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
11/22/2011	US8063029 Pharmaceutical composition
11/22/2011	CA2528223C Colchicoside analogues
11/22/2011	CA2489902C Thiazole derivatives as phosphodiesterase iv inhibitors
11/17/2011	WO2011143526A2 Topical peripheral neuro-affective (tpna) therapy
11/17/2011	WO2011143187A2 Lactoferrin -based biomaterials for tissue regeneration and drug delivery
11/17/2011	WO2011143152A2 Acth for treatment of amyotrophic lateral sclerosis
11/17/2011	WO2011143008A1 Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same
11/17/2011	WO2011142316A1 Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity
11/17/2011	WO2011141891A1 Use of cycloundecadepsipeptide compounds
11/17/2011	US20110281933 Methods and compositions for the management of cardiovascular disease with oligonucleotides
11/17/2011	US20110281911 Novel forms of eperisone
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281884 Fused derivatives as pi3kdelta inhibitors
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011	US20110280973 Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
11/17/2011	US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011	US20110280878 Substance specific to human pd-1
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110280871 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280840 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/17/2011	CA2798957A1 Lactoferrin-based biomaterials for tissue regeneration and drug delivery
11/16/2011	EP2386636A2 ENA nucleic acid drugs modifying splicing in mRNA precursor
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2386317A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386316A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386315A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/16/2011	EP2386305A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
11/16/2011	EP2386304A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
11/16/2011	CN102245602A Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
11/16/2011	CN102241657A Synthesis of isoflavone compound through Stille crossed coupling reaction
11/16/2011	CN102240368A Chinese medicinal preparation for treating tetanus
11/16/2011	CN102008674B Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof
11/16/2011	CN101837024B Quick-acting medicament for curing tic disorder disease
11/16/2011	CN101411833B Dragon's blood extract as well as preparation method and application thereof
11/16/2011	CN101357144B Selaginella uncinata extraction, its preparation method and application
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058277 Substituted indoles
11/15/2011	US8057789 Hematopoietic stem cell culture for use in treatment of blood disorders; regenerative medicine; tissue engineering
11/15/2011	CA2648155C Use of n- ( dibenz (b, f) oxepin-10-ylmethyl ) n-methyl-n- prop- 2 -ynylamine (omigapil) for the prophylaxis and / or treatment of congenital muscular dystrophy or myopathy resulting from collagen vi deficiency
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2429979C Treatment of statin side effects
11/15/2011	CA2267197C Isolation and use of motoneuronotrophic factors
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275679 Flupirtine hydrochloride maleic acid cocrystal
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110274773 Copper(I) Chloride Complex Of Nicotinic Acid And Pharmaceutical Compositions Containing The Same
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	CN1248288B Nuclear transfer with differentiated fetal and adult donor cells
11/09/2011	CN102239164A 2h-chromene compound and derivative thereof
11/09/2011	CN102232938A Metaxalone capsule and preparation method thereof
11/09/2011	CN101698094B Distillate for treating white vein diseases and preparation method thereof
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	CA2506762C An organic extract of geum japonicum thumb variant and use thereof
11/03/2011	WO2011135969A1 Method for producing induced pluripotent stem cells
11/03/2011	WO2011065791A3 Metabolism accelerating composition comprising astragali radix extract
11/03/2011	WO2011055944A3 Methods for treating fibromyalgia syndrome
11/03/2011	US20110269970 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
11/03/2011	US20110269820 Spinal muscular atrophy treatment via targeting smn2 catalytic core
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269768 Urotensin ii receptor antagonists
11/03/2011	US20110269727 Composition to reduce allodynic back pain and related method of use
11/03/2011	US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269681 Prolactin Induced Increase in Neural Stem Cell Numbers
11/03/2011	US20110269665 Compound and method for treating myotonic dystrophy
11/03/2011	US20110268736 Method for treating congenital myopathy
11/03/2011	US20110268732 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268714 CD34 Stem Cell-Related Methods and Compositions
11/02/2011	EP2382991A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/02/2011	EP2382984A2 GRF analog compositions and their use
11/02/2011	EP2382206A2 Compounds and methods for the treatment of pain and other diseases
11/02/2011	EP2381948A2 Compounds and methods for enhancing erythropoiesis
11/02/2011	CN102228696A Polyethylene glycol-polyvinyl alcohol copolymer-metaxalone prodrug and synthesis method thereof
11/02/2011	CN102228452A Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof
11/01/2011	US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2468826C Benzazole derivatives for the treatment of scleroderma
11/01/2011	CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases
10/2011
10/27/2011	WO2011133985A1 Formation of neuromuscular junctions in a defined system
10/27/2011	WO2011130908A1 Substituted pyrimidines
10/27/2011	US20110263711 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis
10/27/2011	US20110263702 Methods and Compositions for Improved Chromium Complexes
10/27/2011	US20110263686 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
10/27/2011	US20110263682 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50-53

1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 233